Fonte: Quintessence International. Unidade: FO
Assuntos: XEROSTOMIA, SALIVA ARTIFICIAL, SÍNDROME DE SJOGREN
ABNT
ALVES, Marilene B. et al. Saliva substitute in xerostomic patients with primary Sjogren's syndrome: a single-blind trial. Quintessence International, v. 35, n. 5, p. 392-396, 2004Tradução . . Acesso em: 25 ago. 2024.APA
Alves, M. B., Motta, A. C. F., Messina, W. C., & Migliari, D. A. (2004). Saliva substitute in xerostomic patients with primary Sjogren's syndrome: a single-blind trial. Quintessence International, 35( 5), 392-396.NLM
Alves MB, Motta ACF, Messina WC, Migliari DA. Saliva substitute in xerostomic patients with primary Sjogren's syndrome: a single-blind trial. Quintessence International. 2004 ; 35( 5): 392-396.[citado 2024 ago. 25 ]Vancouver
Alves MB, Motta ACF, Messina WC, Migliari DA. Saliva substitute in xerostomic patients with primary Sjogren's syndrome: a single-blind trial. Quintessence International. 2004 ; 35( 5): 392-396.[citado 2024 ago. 25 ]